Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MDVN > SEC Filings for MDVN > Form 8-K on 1-Apr-2013All Recent SEC Filings

Show all filings for MEDIVATION, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for MEDIVATION, INC.


1-Apr-2013

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On April 1, 2013, Medivation and Astellas Pharma Inc. issued a press release announcing that the companies have established an updated interim analysis plan for the PREVAIL trial, a global Phase 3 clinical trial evaluating XTANDIŽ(enzalutamide) capsules in men with metastatic castration-resistant prostate cancer who have not yet received chemotherapy. A copy of the press release is attached hereto as Exhibit 99.1 and is also incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1 Joint Press Release dated April 1, 2013, providing update on PREVAIL trial.


  Add MDVN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MDVN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.